Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

Indian equities brace for a roller coaster session on Thursday, April 3, as US President Donald Trump, in the early hours of ...

It’s a party for pharma stocks on Dalal Street. The Nifty Plarma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...

AM, all 20 Nifty Pharma constituents traded in the green. Among others, Gland Pharma was up 7.74 per cent, Lupin was up over ...

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company."With ...

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from ...

India pharmaceutical stocks soared today after US President Donald Trump imposed a 26% reciprocal tariff on India but excluded the pharma sector from the levies.

Pharma stocks surge after US exempts products from tariffs, Nifty Pharma and healthcare indices show positive gains.

"Roche has filed an appeal against the Hon. Delhi High Court order and the matter is subjudice in the appeal court," Roche ...

In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by ...